Citations (43)
Keep up to date with the latest research on this topic with citation updates for this article.
Articles from other publishers (43)
Dennis Steenhuis, Xuechun Li, Talitha Feenstra, Eelko Hak & Stijn de Vos. (2023) The Association between Deductibles and Cardiovascular Medication Adherence: A Retrospective Inception Cohort Study. Drugs - Real World Outcomes.
Crossref
Crossref
Anja A. Withagen-Koster, Richard C. van Kleef & Frank Eijkenaar. (2023) Predictable profits and losses in a health insurance market with risk equalization: A multiple-contract period perspective. Health Policy 131, pages 104763.
Crossref
Crossref
Pardis Birzhandi & Yoon-Sik Cho. (2023) Application of fairness to healthcare, organizational justice, and finance: A survey. Expert Systems with Applications 216, pages 119465.
Crossref
Crossref
Frank J. P. van der Hulst, Anne E. M. Brabers & Judith D. de Jong. (2023) The relation between trust and the willingness of enrollees to receive healthcare advice from their health insurer. BMC Health Services Research 23:1.
Crossref
Crossref
A. A. Withagen-Koster, R. C. van Kleef & F. Eijkenaar. (2022) Selection Incentives in the Dutch Basic Health Insurance: To What Extent Does End-of-Life Spending Contribute to Predictable Profits and Losses for Selective Groups?. Medical Care Research and Review 79:6, pages 819-833.
Crossref
Crossref
Rose J. Geurten, Jeroen N. Struijs, Arianne M. J. Elissen, Henk J. G. Bilo, Chantal van Tilburg & Dirk Ruwaard. (2021) Delineating the Type 2 Diabetes Population in the Netherlands Using an All-Payer Claims Database: Specialist Care, Medication Utilization and Expenditures 2016–2018. PharmacoEconomics - Open 6:2, pages 219-229.
Crossref
Crossref
Rose J Geurten, Arianne M J Elissen, Henk J G Bilo, Jeroen N Struijs, Chantal van Tilburg & Dirk Ruwaard. (2021) Identifying and delineating the type 2 diabetes population in the Netherlands using an all-payer claims database: characteristics, healthcare utilisation and expenditures. BMJ Open 11:12, pages e049487.
Crossref
Crossref
Thomas G. McGuire, Anna L. Zink & Sherri Rose. (2021) Improving the Performance of Risk Adjustment Systems. American Journal of Health Economics 7:4, pages 497-521.
Crossref
Crossref
Simón Ramírez, Adolfo J Quiroz & Alvaro J Riascos. (2021) A supervised clustering MCMC methodology for large categorical feature spaces. Statistical Methods in Medical Research 30:7, pages 1708-1724.
Crossref
Crossref
Thomas Rice. 2021. Health Insurance Systems. Health Insurance Systems
173
187
.
Sigrid M. Mohnen, Adriënne H. Rotteveel, Gerda Doornbos & Johan J. Polder. (2020) Healthcare Expenditure Prediction with Neighbourhood Variables – A Random Forest Model. Statistics, Politics and Policy 11:2, pages 111-138.
Crossref
Crossref
Richard C. van Kleef, Frank Eijkenaar & René C. J. A. van Vliet. (2019) Selection Incentives for Health Insurers in the Presence of Sophisticated Risk Adjustment. Medical Care Research and Review 77:6, pages 584-595.
Crossref
Crossref
Rob J. M. Alessie, Viola Angelini, Jochen O. Mierau & Laura Viluma. (2020) Moral hazard and selection for voluntary deductibles. Health Economics 29:10, pages 1251-1269.
Crossref
Crossref
Anna Zink & Sherri Rose. (2020) Fair regression for health care spending. Biometrics 76:3, pages 973-982.
Crossref
Crossref
Sigrid M. Mohnen, Sven Schneider & Mariël Droomers. (2019) Neighborhood characteristics as determinants of healthcare utilization – a theoretical model. Health Economics Review 9:1.
Crossref
Crossref
Danny Wende. (2019) Spatial risk adjustment between health insurances: using GWR in risk adjustment models to conserve incentives for service optimisation and reduce MAUP. The European Journal of Health Economics 20:7, pages 1079-1091.
Crossref
Crossref
Jan Boone & Christoph Schottmüller. (2019) DO HEALTH INSURERS CONTRACT THE BEST PROVIDERS? PROVIDER NETWORKS, QUALITY, AND COSTS. International Economic Review 60:3, pages 1209-1247.
Crossref
Crossref
Lucie Bryndová, Pavel Hroboň & Henrieta Tulejová. (2019) The 2018 risk-adjustment reform in the Czech Republic: Introducing Pharmacy-based Cost Groups and strengthening reinsurance. Health Policy 123:8, pages 700-705.
Crossref
Crossref
Savannah L. Bergquist, Timothy J. Layton, Thomas G. McGuire & Sherri Rose. (2019) Data transformations to improve the performance of health plan payment methods. Journal of Health Economics 66, pages 195-207.
Crossref
Crossref
Alexander Karmann, Ines Weinhold & Danny Wende. (2019) Area Deprivation and its Impact on Population Health: Conceptual Aspects, Measurement and Evidence from Germany. Review of Economics 70:1, pages 69-98.
Crossref
Crossref
Julie Shi, Yi Yao & Gordon Liu. (2018) Modeling individual health care expenditures in China: Evidence to assist payment reform in public insurance. Health Economics 27:12, pages 1945-1962.
Crossref
Crossref
Vicki Fung, Cassandra G. K. Peitzman, Julie Shi, Catherine Y. Liang, William H. Dow, Alan M. Zaslavsky, Bruce H. Fireman, Stephen F. Derose, Michael E. Chernew, Joseph P. Newhouse & John Hsu. (2018) Adverse Selection into and within the Individual Health Insurance Market in California in 2014. Health Services Research 53:5, pages 3750-3769.
Crossref
Crossref
Paul E. Orzechowski. (2018) The Case for a Private Healthcare Insurance Monopoly. Applied Health Economics and Health Policy 16:4, pages 433-443.
Crossref
Crossref
K. P. M. van Winssen, R. C. van Kleef & W. P. M. M. van de Ven. (2017) Can premium differentiation counteract adverse selection in the Dutch supplementary health insurance? A simulation study. The European Journal of Health Economics 19:5, pages 757-768.
Crossref
Crossref
Frank Eijkenaar & René C. J. A. van Vliet. (2017) Improving risk equalization using information on physiotherapy diagnoses. The European Journal of Health Economics 19:2, pages 203-211.
Crossref
Crossref
Frank Eijkenaar, René C.J.A. van Vliet & Richard C. van Kleef. (2018) Diagnosis-based Cost Groups in the Dutch Risk-equalization Model. Medical Care 56:1, pages 91-96.
Crossref
Crossref
. 2018. Risk Adjustment, Risk Sharing and Premium Regulation in Health Insurance Markets. Risk Adjustment, Risk Sharing and Premium Regulation in Health Insurance Markets
169
177
.
Richard C. van Kleef, Frank Eijkenaar, René C.J.A. van Vliet & Wynand P.M.M. van de Ven. 2018. Risk Adjustment, Risk Sharing and Premium Regulation in Health Insurance Markets. Risk Adjustment, Risk Sharing and Premium Regulation in Health Insurance Markets
397
429
.
Timothy J. Layton, Randall P. Ellis, Thomas G. McGuire & Richard van Kleef. (2017) Measuring efficiency of health plan payment systems in managed competition health insurance markets. Journal of Health Economics 56, pages 237-255.
Crossref
Crossref
Sherri Rose, Julie Shi, Thomas G. McGuire & Sharon-Lise T. Normand. (2015) Matching and Imputation Methods for Risk Adjustment in the Health Insurance Marketplaces. Statistics in Biosciences 9:2, pages 525-542.
Crossref
Crossref
Richard C. van Kleef, Thomas G. McGuire, René C. J. A. van Vliet & Wynand P. P. M. van de Ven. (2016) Improving risk equalization with constrained regression. The European Journal of Health Economics 18:9, pages 1137-1156.
Crossref
Crossref
Frank Eijkenaar & René C.J.A. van Vliet. (2017) Improving risk equalization for individuals with persistently high costs: Experiences from the Netherlands. Health Policy 121:11, pages 1169-1176.
Crossref
Crossref
Rudy Douven, Katalin Katona, Frederik T. Schut & Victoria Shestalova. (2017) Switching gains and health plan price elasticities: 20 years of managed competition reforms in The Netherlands. The European Journal of Health Economics 18:8, pages 1047-1064.
Crossref
Crossref
Daniëlle M.I.D. Willemse-Duijmelinck, Wynand P.M.M. van de Ven & Ilaria Mosca. (2017) Supplementary insurance as a switching cost for basic health insurance: Empirical results from the Netherlands. Health Policy 121:10, pages 1085-1092.
Crossref
Crossref
Normann Lorenz. (2017) Using Quantile and Asymmetric Least Squares Regression for Optimal Risk Adjustment. Health Economics 26:6, pages 724-742.
Crossref
Crossref
K. P. M. van Winssen, R. C. van Kleef & W. P. M. M. van de Ven. (2016) A voluntary deductible in health insurance: the more years you opt for it, the lower your premium?. The European Journal of Health Economics 18:2, pages 209-226.
Crossref
Crossref
R. C. van Kleef, R. C. J. A. van Vliet & W. P. M. M. van de Ven. (2015) Overpaying morbidity adjusters in risk equalization models. The European Journal of Health Economics 17:7, pages 885-895.
Crossref
Crossref
Christian P.R. Schmid & Konstantin Beck. (2016) Re-insurance in the Swiss health insurance market: Fit, power, and balance. Health Policy 120:7, pages 848-855.
Crossref
Crossref
Daniëlle M.I.D. Duijmelinck & Wynand P.M.M. van de Ven. (2015) Switching rates in health insurance markets decrease with age: empirical evidence and policy implications from the Netherlands. Health Economics, Policy and Law 11:02, pages 141-159.
Crossref
Crossref
Lieke H. H. M. Boonen, Trea Laske-Aldershof & Frederik T. Schut. (2015) Switching health insurers: the role of price, quality and consumer information search. The European Journal of Health Economics 17:3, pages 339-353.
Crossref
Crossref
Viktor von Wyl & Konstantin Beck. (2015) Do insurers respond to risk adjustment? A long-term, nationwide analysis from Switzerland. The European Journal of Health Economics 17:2, pages 171-183.
Crossref
Crossref
Wynand P. M. M. van de VenRichard C. van KleefRene C. J. A. van Vliet. (2015) Risk Selection Threatens Quality Of Care For Certain Patients: Lessons From Europe’s Health Insurance Exchanges. Health Affairs 34:10, pages 1713-1720.
Crossref
Crossref
K.P.M. van Winssen, R.C. van Kleef & W.P.M.M. van de Ven. (2015) How profitable is a voluntary deductible in health insurance for the consumer?. Health Policy 119:5, pages 688-695.
Crossref
Crossref